These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

138 related items for PubMed ID: 12724316

  • 21. Contributions of leukemia inhibitory factor receptor and oncostatin M receptor to signal transduction in heterodimeric complexes with glycoprotein 130.
    Hermanns HM, Radtke S, Haan C, Schmitz-Van de Leur H, Tavernier J, Heinrich PC, Behrmann I.
    J Immunol; 1999 Dec 15; 163(12):6651-8. PubMed ID: 10586060
    [Abstract] [Full Text] [Related]

  • 22. Reciprocal regulation of gastrointestinal homeostasis by SHP2 and STAT-mediated trefoil gene activation in gp130 mutant mice.
    Tebbutt NC, Giraud AS, Inglese M, Jenkins B, Waring P, Clay FJ, Malki S, Alderman BM, Grail D, Hollande F, Heath JK, Ernst M.
    Nat Med; 2002 Oct 15; 8(10):1089-97. PubMed ID: 12219085
    [Abstract] [Full Text] [Related]

  • 23. The protein tyrosine phosphatase SHP-2 negatively regulates ciliary neurotrophic factor induction of gene expression.
    Symes A, Stahl N, Reeves SA, Farruggella T, Servidei T, Gearan T, Yancopoulos GD, Fink JS.
    Curr Biol; 1997 Sep 01; 7(9):697-700. PubMed ID: 9285712
    [Abstract] [Full Text] [Related]

  • 24. Defective gp130-mediated signal transducer and activator of transcription (STAT) signaling results in degenerative joint disease, gastrointestinal ulceration, and failure of uterine implantation.
    Ernst M, Inglese M, Waring P, Campbell IK, Bao S, Clay FJ, Alexander WS, Wicks IP, Tarlinton DM, Novak U, Heath JK, Dunn AR.
    J Exp Med; 2001 Jul 16; 194(2):189-203. PubMed ID: 11457894
    [Abstract] [Full Text] [Related]

  • 25. A family of cytokine-inducible inhibitors of signalling.
    Starr R, Willson TA, Viney EM, Murray LJ, Rayner JR, Jenkins BJ, Gonda TJ, Alexander WS, Metcalf D, Nicola NA, Hilton DJ.
    Nature; 1997 Jun 26; 387(6636):917-21. PubMed ID: 9202125
    [Abstract] [Full Text] [Related]

  • 26. Comparative study of gp130 cytokine effects on corticotroph AtT-20 cells--redundancy or specificity of neuroimmunoendocrine modulators?
    Auernhammer CJ, Kopp FB, Vlotides G, Dorn F, Isele NB, Spöttl G, Cengic N, Weber MM, Senaldi G, Engelhardt D.
    Neuroimmunomodulation; 2004 Jun 26; 11(4):224-32. PubMed ID: 15249728
    [Abstract] [Full Text] [Related]

  • 27. PD-1 immunoreceptor inhibits B cell receptor-mediated signaling by recruiting src homology 2-domain-containing tyrosine phosphatase 2 to phosphotyrosine.
    Okazaki T, Maeda A, Nishimura H, Kurosaki T, Honjo T.
    Proc Natl Acad Sci U S A; 2001 Nov 20; 98(24):13866-71. PubMed ID: 11698646
    [Abstract] [Full Text] [Related]

  • 28. Novel neurotrophin-1/B cell-stimulating factor-3 (cardiotrophin-like cytokine) stimulates corticotroph function via a signal transducer and activator of transcription-dependent mechanism negatively regulated by suppressor of cytokine signaling-3.
    Auernhammer CJ, Isele NB, Kopp FB, Spoettl G, Cengic N, Weber MM, Senaldi G, Engelhardt D.
    Endocrinology; 2003 Apr 20; 144(4):1202-10. PubMed ID: 12639901
    [Abstract] [Full Text] [Related]

  • 29. SOCS-1, -2, -3: selective targets and functions downstream of the prolactin receptor.
    Tomic S, Chughtai N, Ali S.
    Mol Cell Endocrinol; 1999 Dec 20; 158(1-2):45-54. PubMed ID: 10630404
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. A novel SHP-1/Grb2-dependent mechanism of negative regulation of cytokine-receptor signaling: contribution of SHP-1 C-terminal tyrosines in cytokine signaling.
    Minoo P, Zadeh MM, Rottapel R, Lebrun JJ, Ali S.
    Blood; 2004 Feb 15; 103(4):1398-407. PubMed ID: 14551136
    [Abstract] [Full Text] [Related]

  • 33. Activation of gp130 transduces hypertrophic signal through interaction of scaffolding/docking protein Gab1 with tyrosine phosphatase SHP2 in cardiomyocytes.
    Nakaoka Y, Nishida K, Fujio Y, Izumi M, Terai K, Oshima Y, Sugiyama S, Matsuda S, Koyasu S, Yamauchi-Takihara K, Hirano T, Kawase I, Hirota H.
    Circ Res; 2003 Aug 08; 93(3):221-9. PubMed ID: 12855672
    [Abstract] [Full Text] [Related]

  • 34. Interleukin-6-type cytokine signalling through the gp130/Jak/STAT pathway.
    Heinrich PC, Behrmann I, Müller-Newen G, Schaper F, Graeve L.
    Biochem J; 1998 Sep 01; 334 ( Pt 2)(Pt 2):297-314. PubMed ID: 9716487
    [Abstract] [Full Text] [Related]

  • 35. Activation of the Jak-Stat- and MAPK-pathways by oncostatin M is not sufficient to cause growth inhibition of human glioma cells.
    Halfter H, Postert C, Friedrich M, Ringelstein EB, Stögbauer F.
    Brain Res Mol Brain Res; 2000 Sep 15; 80(2):198-206. PubMed ID: 11038252
    [Abstract] [Full Text] [Related]

  • 36. Specificity of the SH2 domains of SHP-1 in the interaction with the immunoreceptor tyrosine-based inhibitory motif-bearing receptor gp49B.
    Wang LL, Blasioli J, Plas DR, Thomas ML, Yokoyama WM.
    J Immunol; 1999 Feb 01; 162(3):1318-23. PubMed ID: 9973385
    [Abstract] [Full Text] [Related]

  • 37. Fill a Gab(1) in cardiac hypertrophy signaling: search a missing link between gp130 and ERK5 in hypertrophic remodeling in heart.
    Wang Y.
    Circ Res; 2003 Aug 08; 93(3):186-8. PubMed ID: 12907663
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Suppression of SHP-2 and ERK signalling promotes self-renewal of mouse embryonic stem cells.
    Burdon T, Stracey C, Chambers I, Nichols J, Smith A.
    Dev Biol; 1999 Jun 01; 210(1):30-43. PubMed ID: 10364425
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.